MX2013009585A - Derivado de macrolido sustituido en la posicion c-4. - Google Patents

Derivado de macrolido sustituido en la posicion c-4.

Info

Publication number
MX2013009585A
MX2013009585A MX2013009585A MX2013009585A MX2013009585A MX 2013009585 A MX2013009585 A MX 2013009585A MX 2013009585 A MX2013009585 A MX 2013009585A MX 2013009585 A MX2013009585 A MX 2013009585A MX 2013009585 A MX2013009585 A MX 2013009585A
Authority
MX
Mexico
Prior art keywords
macrolido
derivative replaced
derivative
replaced
formula
Prior art date
Application number
MX2013009585A
Other languages
English (en)
Spanish (es)
Inventor
Tomohiro Sugimoto
Naoki Sasamoto
Kurosakajun
Masato Hayashi
Kanako Yamamoto
Masato Kashimura
Yasunobu Ushiki
Haruhisa Ogita
Tomoaki Miura
Kenichi Kanemoto
Kou Kumura
Satoshi Yoshida
Keiji Tamura
Eiki Shitara
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013009585(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of MX2013009585A publication Critical patent/MX2013009585A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX2013009585A 2011-02-21 2012-02-20 Derivado de macrolido sustituido en la posicion c-4. MX2013009585A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011034578 2011-02-21
PCT/JP2012/054677 WO2012115256A1 (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Publications (1)

Publication Number Publication Date
MX2013009585A true MX2013009585A (es) 2014-06-05

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009585A MX2013009585A (es) 2011-02-21 2012-02-20 Derivado de macrolido sustituido en la posicion c-4.

Country Status (35)

Country Link
US (1) US9139609B2 (enExample)
EP (1) EP2678349B1 (enExample)
JP (1) JP5687777B2 (enExample)
KR (1) KR20140008388A (enExample)
CN (1) CN103492404B (enExample)
AR (1) AR085286A1 (enExample)
AU (1) AU2012222267B2 (enExample)
BR (1) BR112013020118A2 (enExample)
CA (1) CA2827474A1 (enExample)
CL (1) CL2013002313A1 (enExample)
CO (1) CO6801737A2 (enExample)
CY (1) CY1117381T1 (enExample)
DK (1) DK2678349T3 (enExample)
ES (1) ES2566368T3 (enExample)
HR (1) HRP20160252T1 (enExample)
HU (1) HUE028245T2 (enExample)
IL (1) IL227663A (enExample)
IN (1) IN2013CN07459A (enExample)
ME (1) ME02475B (enExample)
MX (1) MX2013009585A (enExample)
MY (1) MY161451A (enExample)
NZ (1) NZ613956A (enExample)
PE (1) PE20140649A1 (enExample)
PH (1) PH12013501695B1 (enExample)
PL (1) PL2678349T3 (enExample)
RS (1) RS54635B1 (enExample)
RU (1) RU2599718C2 (enExample)
SA (1) SA112330287B1 (enExample)
SG (1) SG192655A1 (enExample)
SI (1) SI2678349T1 (enExample)
SM (1) SMT201600106B (enExample)
TW (1) TWI513704B (enExample)
UA (1) UA111191C2 (enExample)
WO (1) WO2012115256A1 (enExample)
ZA (1) ZA201305983B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN105085590A (zh) * 2014-05-16 2015-11-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202535873A (zh) 2019-09-26 2025-09-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希(南京)药物研发有限公司 一种同位素标记的红霉胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
ES2242983T3 (es) 1996-09-04 2005-11-16 Abbott Laboratories Cetolidos 6-0-sustituidos que tienen una actividad antibacteriana.
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
BR0010938A (pt) * 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same
WO2008143729A2 (en) * 2007-02-28 2008-11-27 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same

Also Published As

Publication number Publication date
RS54635B1 (sr) 2016-08-31
SA112330287B1 (ar) 2015-10-11
IN2013CN07459A (enExample) 2015-04-24
SI2678349T1 (sl) 2016-04-29
EP2678349B1 (en) 2016-01-13
TW201247693A (en) 2012-12-01
HRP20160252T1 (hr) 2016-04-22
EP2678349A1 (en) 2014-01-01
PH12013501695B1 (en) 2018-07-11
CY1117381T1 (el) 2017-04-26
US9139609B2 (en) 2015-09-22
JP5687777B2 (ja) 2015-03-18
CN103492404A (zh) 2014-01-01
BR112013020118A2 (pt) 2017-07-18
DK2678349T3 (en) 2016-03-07
HUE028245T2 (en) 2016-12-28
TWI513704B (zh) 2015-12-21
CA2827474A1 (en) 2012-08-30
US20140046043A1 (en) 2014-02-13
WO2012115256A1 (en) 2012-08-30
RU2599718C2 (ru) 2016-10-10
CN103492404B (zh) 2016-09-07
AU2012222267A1 (en) 2013-08-22
JP2014505723A (ja) 2014-03-06
PL2678349T3 (pl) 2016-06-30
SMT201600106B (it) 2016-04-29
AU2012222267B2 (en) 2016-07-07
CO6801737A2 (es) 2013-11-29
ZA201305983B (en) 2014-11-26
ES2566368T3 (es) 2016-04-12
IL227663A0 (en) 2013-09-30
EP2678349A4 (en) 2014-07-30
CL2013002313A1 (es) 2014-08-08
RU2013142898A (ru) 2015-03-27
KR20140008388A (ko) 2014-01-21
AR085286A1 (es) 2013-09-18
SG192655A1 (en) 2013-09-30
IL227663A (en) 2017-09-28
ME02475B (me) 2017-02-20
PH12013501695A1 (en) 2013-10-07
NZ613956A (en) 2014-07-25
UA111191C2 (uk) 2016-04-11
MY161451A (en) 2017-04-14
PE20140649A1 (es) 2014-06-25

Similar Documents

Publication Publication Date Title
MX2013009585A (es) Derivado de macrolido sustituido en la posicion c-4.
ITRM20110140A1 (it) Dispositivo di controllo per macchina utensile.
ITRM20120052A1 (it) Valvola di ritegno a piastra doppia.
BR112014008858A2 (pt) mecanismo de comando, volume fechado e dispositivo de tranferência
BR112013006486A2 (pt) símbolos legíveis por máquina.
BR112013030877A2 (pt) processamento de biomassa.
ITRM20120030A1 (it) Apparato di controllo della posizione.
BR112012029586A2 (pt) processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
EP2625178A4 (en) BACTERIA TOPOISOMERASE II FOR INHIBITING 2-ETHYL CARBAMOYLAMINE-1,3-BENZOTHIAZOL-5-YLENE
EP2462775A4 (en) EARLY PREVENTION OF COLLISIONS BASED ON CHANNEL OCCUPANCY
ITTO20120218A1 (it) Dispositivo di controllo del rapporto aria-carburante.
EP2763609A4 (en) OPTIMIZED PNEUMATIC DRIVE LINES
ZA201404176B (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
PH12016502357A1 (en) Polyene macrolide derivative
MX2017007147A (es) Metodos y reactivos para detectar neisseria gonorrhoeae y sus determinantes de resistencia antimicrobiana.
EP2877400A4 (en) FLUID VALVE CONTROLLED FUEL TRANSFER SYSTEM
CL2009001973S1 (es) Mostrador.
CL2014002578A1 (es) Adyuvante que comprende nanopartículas inorgánicas, particularmente de óxido de cobalto.
GB2497643B (en) Sending messages by oblivious transfer
ITTO20120262A1 (it) Impianto per la stampa di nastri di tessuto.
IT1399346B1 (it) Dispositivo di introduzione per macchine rullatrici.
ES2437716B1 (es) Seguidor de velocidad adaptativa.
FI20096228A0 (sv) Rullskärmaskins förflyttningsväxlare.
ES2388512B1 (es) Avion-lanzadera propulsado por conotubos aceleradores de fluidos.
ES1074860Y (es) Dispositivo de ventilacion entre estancias adyacentescomunicadas por una puerta

Legal Events

Date Code Title Description
FG Grant or registration